Zishen Qingre Lishi Huayu recipe improves polycystic ovary syndrome by restoring granulosa cell homeostasis via C/EBPβ/STAT3 signaling
Journal of Ethnopharmacology · 2026
DOI: 10.1016/j.jep.2026.122019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2026. Verfasst von Jing Jin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi University of Chinese Medicine, Nanchang, Jiangxi Province, 330004, China. Electronic address: 1509235942@qq.com. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Granulosa Cells, Drugs, Chinese Herbal, CCAAT-Enhancer-Binding Protein-beta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Department of Science and Technology.
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder characterized by ovulation disorders. Zishen Qingre Lishi Huayu Recipe (ZQLHR), a traditional Chinese medicine (TCM) formula, has shown clinical efficacy by effectively increasing the ovulation rate and menstrual cycle regularity in patients with PCOS and is widely used in practice; however, its underlying pharmacological mechanism has not been fully elucidated. AIM OF THE STUDY: Aim of the study: This study aimed to elucidate how ZQLHR modulates the proliferation-apoptosis balance of ovarian granulosa cells (GCs) in PCOS via the C/EBPβ/STAT3 signaling axis. METHODS: Human granulosa cells (hGCs) from PCOS and non-PCOS patients were analyzed for proliferation, apoptosis, and C/EBPβ/STAT3 expression. In vivo, letrozole-induced PCOS mice were subjected to scAAV-mediated C/EBPβ knockdown, followed by administration of ZQLHR to evaluate treatment outcomes. In vitro, C/EBPβ or STAT3 was silenced in Human granulosa-like tumor cell line (KGN) cells to explore their regulatory relationship and roles in proliferation and apoptosis. Additionally, ZQLHR effects were evaluated in a dose- and time-dependent manner. Notably, CETSA was employed to confirm for the first time direct binding of ZQLHR to C/EBPβ, and C/EBPβ-silenced cells were subsequently treated with ZQLHR to examine whether its effects involve C/EBPβ-dependent STAT3. The pharmacological mechanism of ZQLHR was further evaluated through histological and molecular biology experiments. RESULTS: PCOS patient-derived GCs exhibited reduced proliferation, elevated apoptosis, and decreased C/EBPβ/STAT3 expression. In LET-induced PCOS mice, ZQLHR treatment significantly improved estrous cycle regularity, hormonal balance, follicular development, and GC apoptosis, accompanied by modulation of the C/EBPβ/STAT3 pathway. C/EBPβ knockdown exacerbated ovarian dysfunction and KGN apoptosis, whereas ZQLHR attenuated these effects and partially restored pathway activity. In vitro, C/EBPβ and STAT3 influenced each other and CFTR expression, associated with changes in proliferation and apoptosis. ZQLHR increased proliferation markers (PCNA, cyclin D1) and decreased apoptosis markers (Caspase-3, PARP) in a dose- and time-dependent manner, with CETSA confirming direct binding to C/EBPβ. Notably, despite C/EBPβ knockdown, ZQLHR partially restored KGN cell proliferation and modestly modulated the C/EBPβ/STAT3 signaling pathway. CONCLUSION: ZQLHR improves GC homeostasis and promotes follicular development in PCOS by modulating the C/EBPβ/STAT3 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangxi University of Chinese Medicine, Nanchang, Jiangxi Province, 330004, China. Electronic address: 1509235942@qq.com.
- Jiangxi University of Chinese Medicine, Nanchang, Jiangxi Province, 330004, China; The Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, Jiangxi Province, 330006, China; Institute of Obstetrics an…
- The Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, Jiangxi Province, 330006, China. Electronic address: 1741276578@qq.com.
- Jiangxi University of Chinese Medicine, Nanchang, Jiangxi Province, 330004, China; Institute of Obstetrics and Gynecology, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi Province, 330006, China. Electronic ad…
Förderung
- National Natural Science Foundation of China
- Jiangxi Provincial Department of Science and Technology
Zitieren
APA
Jin, J., Li, P., Yu, X., Ding, Z., Peng, J., Liu, C., Yi, Y., & Liang, R. (2026). Zishen Qingre Lishi Huayu recipe improves polycystic ovary syndrome by restoring granulosa cell homeostasis via C/EBPβ/STAT3 signaling. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2026.122019
Vancouver
Jin J, Li P, Yu X, Ding Z, Peng J, Liu C, et al. Zishen Qingre Lishi Huayu recipe improves polycystic ovary syndrome by restoring granulosa cell homeostasis via C/EBPβ/STAT3 signaling. Journal of Ethnopharmacology. 2026. doi:10.1016/j.jep.2026.122019
BibTeX
@article{Jin2026,
author = {Jin, Jing and Li, Peishuang and Yu, Xingxing and Ding, Zhilin and Peng, Jiahua and Liu, Chengyi and Yi, Yao and Liang, Ruining},
title = {Zishen Qingre Lishi Huayu recipe improves polycystic ovary syndrome by restoring granulosa cell homeostasis via C/EBPβ/STAT3 signaling},
journal = {Journal of Ethnopharmacology},
year = {2026},
doi = {10.1016/j.jep.2026.122019}
}
EUVIMED